7296 results for "canc*"

in 60.33 milliseconds.

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0019_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0019_001 for Triple negative breast cancer patient-derived xenograft SA604X7XB02089

  Dataset EGAD00001011253

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0020_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0020_002 for Triple negative breast cancer patient-derived xenograft SA604X8XB02164

  Dataset EGAD00001011254

• WGS of a Li-Fraumeni patient's HSPCs

  WGS data of clonally expanded HSPCs from a Li-Fraumeni patient at the time of second cancer (Burkitt lymphoma and <5% t-MN) after primary osteosarcoma diagnosis and a reference MSC bulk.

  Dataset EGAD00001011257

• 10x Single Cell Gene Expression Library TENX063

  10x Single Cell Gene Expression library TENX063 for Triple negative breast cancer patient-derived xenograft SA609X3XB01584

  Dataset EGAD00001011268

• Whole-exome sequencing data from head and neck cancer patients

  This dataset contains paired-end whole-exome sequencing data (2x50 bp) from the normal samples, the primary tumors and the recurrences/metastases of 8 head and neck cancer patients.

  Dataset EGAD00001011278

• RNA-seq data from the tumor samples of head and neck cancer patients

  This dataset contains paired-end RNA sequencing data (2x50 bp) from the primary tumors and the recurrences/metastases of 6 head and neck cancer patients.

  Dataset EGAD00001011279

• Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer

  Dataset consists of 216 samples, with each sample having a BAM, BAI and VCF file.

  Dataset EGAD00001011297

• Neoantigen Immunogenicity Landscapes and Evolution of Tumor Ecosystems During Immunotherapy with Nivolumab

  We performed Whole Exome (WXS) and RNASeq sequencing on samples obtained from the same site before and during therapy from our prospective clinical trial (CA209-153, NCT02066636) of nivolumab in advanced Non-small cell lung cancer (NSCLC) patients that progressed on chemotherapy. There are 58 pre and 42 on therapy WXS samples and 24 pre and 12 on therapy RNASeq samples. All WXS tumor samples have matching normal samples.

  Dataset EGAD00001011302

• Whole genome sequencing data of high-grade serous ovarian cancer samples (set 8a)

  Whole genome sequencing data of 26 high-grade serous carcinoma (HGSC) patients (87 samples) sequenced with MGISEQ-2000 and HiSeq X Ten.

  Dataset EGAD00001011304

• INSPIRE multi-timepoint cfMeDIP dataset

  This dataset contains raw sequencing data from multi-timepoint cell-free methylated DNA immunoprecipitation and sequencing (cfMeDIP-seq) of plasma samples from the INSPIRE study (NCT02644369). Details about the study, including inclusion/exclusion criteria and interventions are available at https://clinicaltrials.gov/study/NCT02644369. Briefly, five cohorts were included, INS-A (head & neck squamous cell carcinoma), INS-B (triple-negative breast cancer), INS-C (high-grade serous ovarian cancer), INS-D (melanoma), and INS-E (mixed solid tumors). All patients in the study were diagnosed with advanced cancer and received treatment with pembrolizumab. Plasma samples were collected at baseline and every 3 cycles until disease progression, death, loss of follow-up, or completion of the study. Plasma samples were first processed for cell-free DNA mutations and remaining samples were then processed by cfMeDIP-seq, prioritizing baseline and post-cycle 3 samples. In total, data from 204 timepoints from 87 distinct patients are deposited.

  Dataset EGAD00001011312

• Machine Learning Guided Signal Enrichment for Plasma Tumor-burden Monitoring Dataset

  Includes 4 Datasets: 1. 35 Control Plasma WGS samples sequenced on NovaSeq V1.0 Chemistry at the New York Genome Center. Denoted by CTRL-2XX naming scheme. 2. Plasma WGS from 17 patients with Small Cell Lung Cancer. Samples extracted at either Pretreatment or Postoperative at weeks 2 or 3. Denoted by SCLC-XX naming scheme. 3. Plasma WGS from a synthetic mixing study of a high-burden melanoma plasma sample with plasma bag, at estimated tumor concentrations of 10e-3, 10e-4, 10e-5, and 10e-6 for 2 replicates. Denoted by SM-repX naming scheme. 4. Assorted Plasma, Tumor, and Normal WGS from patients with NSCLC expressing high-burden for use in model training. Denoted by NSCLC-2XX naming scheme.

  Dataset EGAD00001011352

• Whole genome sequencing data of high-grade serous ovarian cancer samples (set 9 part 1)

  Whole genome sequencing data of 6 high-grade serous carcinoma (HGSC) patients (11 samples) sequenced with MGISEQ-2000

  Dataset EGAD00001011353

• neoALTTO

  RNAseq fastq files for 254 samples for the neoALTTO study of lapatinib, trastuzumab or combination in HER2+ breast cancer patients. Those are pre-treatment baseline samples.

  Dataset EGAD00001011354

• Sequence data from stage I of the CCTG BR.36 ctDNA-directed, multi-center phase II study of molecular response adaptive immunotherapy in non-small cell lung cancer

  The dataset for the study "Early ctDNA molecular response captures therapeutic response in the first stage of CCTG BR.36 ctDNA-directed, multi-center phase II study of molecular response adaptive immunotherapy in non-small cell lung cancer", includes 134 bam files from hybrid capture targeted error-correction next-generation sequencing (PGDx Elio plasma resolve) from plasma cell-free DNA and matched white blood cell DNA from 35 individuals with non-small cell lung cancer on the BR.36 trial, alongside 11 bam files from targeted next generation sequencing (PGDx Elio tissue complete) of tumor DNA from 11 individuals with non-small cell lung cancer on the BR.36 trial.

  Dataset EGAD00001011359

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0150_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0150_002 for Triple negative breast cancer sample SA609X5XB03231

  Dataset EGAD00001011213

• Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma - RNA-Seq

  This study aims to investigate the dysregulation of RNA translation and identify functional non-canonical open reading frames (ORFs) as potential targets for medulloblastoma treatment. The study involves ribosome profiling and RNAseq of medulloblastoma tissues and cell lines to observe the translation of non-canonical ORFs. Multiple CRISPR-Cas9 screens will be used to identify functional non-canonical ORFs implicated in medulloblastoma cell survival.

  Dataset EGAD00001011192

• Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma - Ribo-Seq

  This study aims to investigate the dysregulation of RNA translation and identify functional non-canonical open reading frames (ORFs) as potential targets for medulloblastoma treatment. The study involves ribosome profiling and RNAseq of medulloblastoma tissues and cell lines to observe the translation of non-canonical ORFs. Multiple CRISPR-Cas9 screens will be used to identify functional non-canonical ORFs implicated in medulloblastoma cell survival.

  Dataset EGAD00001011193

• 10x Single Cell Gene Expression Library TENX069

  10x Single Cell Gene Expression library TENX069 for Triple negative breast cancer patient-derived xenograft SA609X4XB03083

  Dataset EGAD00001011211

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0150_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0150_001 for Triple negative breast cancer sample SA609X5XB03230

  Dataset EGAD00001011212

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0063_000

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0063_000 for Triple negative breast cancer patient-derived xenograft SA609X3XB01584

  Dataset EGAD00001011209

• 10x Single Cell Gene Expression Library TENX068

  10x Single Cell Gene Expression library TENX068 for Triple negative breast cancer patient-derived xenograft SA609X4XB03080

  Dataset EGAD00001011210

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0146_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0146_002 for Triple negative breast cancer patient-derived xenograft SA609X5XB03223

  Dataset EGAD00001011214

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0152_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0152_001 for Triple negative breast cancer patient-derived xenograft SA609X6XB03401

  Dataset EGAD00001011215

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0152_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0152_002 for Triple negative breast cancer sample SA609X6XB03404

  Dataset EGAD00001011216

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0172_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0172_001 for Triple negative breast cancer sample SA609X6XB03447

  Dataset EGAD00001011217

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0163_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0163_002 for Triple negative breast cancer sample SA609X7XB03510

  Dataset EGAD00001011218

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0163_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0163_001 for Triple negative breast cancer patient-derived xenograft SA609X7XB03505

  Dataset EGAD00001011219

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0172_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0172_002 for Triple negative breast cancer sample SA609X7XB03554

  Dataset EGAD00001011220

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0148_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0148_001 for Triple negative breast cancer patient-derived xenograft SA535X4XB02498

  Dataset EGAD00001011221

• 10x Single Cell Gene Expression Library TENX048

  10x Single Cell Gene Expression library TENX048 for Triple negative breast cancer sample SA535X5XB02895

  Dataset EGAD00001011222

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0146_006

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0146_006 for Triple negative breast cancer sample SA535X6XB03099

  Dataset EGAD00001011223

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0175_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0175_001 for Triple negative breast cancer patient-derived xenograft SA535X6XB03101

  Dataset EGAD00001011224

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0182_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0182_001 for Triple negative breast cancer patient-derived xenograft SA535X7XB03304

  Dataset EGAD00001011225

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0189_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0189_001 for Triple negative breast cancer patient-derived xenograft SA535X7XB03448

  Dataset EGAD00001011226

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0184_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0184_001 for Triple negative breast cancer sample SA535X7XB03305

  Dataset EGAD00001011227

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0146_004

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0146_004 for Triple negative breast cancer sample SA535X7XB03305

  Dataset EGAD00001011228

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0189_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0189_002 for Triple negative breast cancer patient-derived xenograft SA535X8XB03663

  Dataset EGAD00001011229

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0182_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0182_002 for Triple negative breast cancer sample SA535X8XB03431

  Dataset EGAD00001011230

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0184_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0184_002 for Triple negative breast cancer patient-derived xenograft SA535X8XB03434

  Dataset EGAD00001011231

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0173_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0173_002 for Triple negative breast cancer patient-derived xenograft SA535X9XB03617

  Dataset EGAD00001011232

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0173_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0173_001 for Triple negative breast cancer patient-derived xenograft SA535X9XB03616

  Dataset EGAD00001011233

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0195_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0195_001 for Triple negative breast cancer patient-derived xenograft SA535X8XB03664

  Dataset EGAD00001011234

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0206_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0206_002 for Triple negative breast cancer patient-derived xenograft SA535X10XB03696

  Dataset EGAD00001011235

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0206_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0206_001 for Triple negative breast cancer sample SA535X10XB03693

  Dataset EGAD00001011236

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0208_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0208_002 for Triple negative breast cancer patient-derived xenograft SA535X9XB03776

  Dataset EGAD00001011237

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0142_002

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0142_002 for Triple negative breast cancer sample SA1035X4XB02879

  Dataset EGAD00001011238

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0071_000

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0071_000 for Triple negative breast cancer sample SA1035X5XB03015

  Dataset EGAD00001011239

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0076_000

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0076_000 for Triple negative breast cancer sample SA1035X5XB03021

  Dataset EGAD00001011240

• 10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0079_001

  10x Single Cell Gene Expression library SCRNA10X_SA_CHIP0079_001 for Triple negative breast cancer sample SA1035X6XB03216

  Dataset EGAD00001011241

• Whole genome sequencing data of high-grade serous ovarian cancer samples (set 9 part 2)

  Whole genome sequencing data of 35 high-grade serous carcinoma (HGSC) patients (112 samples) sequenced with Illumina Novoseq 6000

  Dataset EGAD00001011368

• An MTOR mutation hitchhikes through renal embryogenesis, driving multifocal, multiphenotypic tumours - WGS

  Embryogenesis is a vulnerable time. Mutations in developmental cells can result in the seeding of cells predisposed to disease within mature organs, creating a field effect. We characterise an embryonic cancer mutation that drives multifocal, multiphenotypic renal tumours in a 14-year-old girl. Their shared MTOR mutation, absent from normal tissues, increases protein flexibility which enables a FAT domain hinge to dramatically increase mTORC1 activity. Developmental mutations, not usually detected in traditional genetic screening, have vital clinical importance in guiding prognosis, targeted treatment, and family screening decisions for paediatric tumours.

  Dataset EGAD00001011645

• An MTOR mutation hitchhikes through renal embryogenesis, driving multifocal, multiphenotypic tumours - RNA

  Embryogenesis is a vulnerable time. Mutations in developmental cells can result in the seeding of cells predisposed to disease within mature organs, creating a field effect. We characterise an embryonic cancer mutation that drives multifocal, multiphenotypic renal tumours in a 14-year-old girl. Their shared MTOR mutation, absent from normal tissues, increases protein flexibility which enables a FAT domain hinge to dramatically increase mTORC1 activity. Developmental mutations, not usually detected in traditional genetic screening, have vital clinical importance in guiding prognosis, targeted treatment, and family screening decisions for paediatric tumours.

  Dataset EGAD00001011646

• An MTOR mutation hitchhikes through renal embryogenesis, driving multifocal, multiphenotypic tumours - scRNA

  Embryogenesis is a vulnerable time. Mutations in developmental cells can result in the seeding of cells predisposed to disease within mature organs, creating a field effect. We characterise an embryonic cancer mutation that drives multifocal, multiphenotypic renal tumours in a 14-year-old girl. Their shared MTOR mutation, absent from normal tissues, increases protein flexibility which enables a FAT domain hinge to dramatically increase mTORC1 activity. Developmental mutations, not usually detected in traditional genetic screening, have vital clinical importance in guiding prognosis, targeted treatment, and family screening decisions for paediatric tumours.

  Dataset EGAD00001011647

• RNA-sequencing of Human Thyroid cancer cell lines

  RNA-sequencing data of 5 human thyroid cancer cell lines cultured in control conditions

  Dataset EGAD00001011677

• Low-coverage whole-genome sequencing of cancer and healthy plasma circulating DNA

  Plasma samples from patients with melanoma (stage II/III/IV) and breast cancer (stage IV) as well as healthy individuals were subjected to low-coverage whole-genome sequencing (less than 10x average depth). This dataset contains raw fastq files from 39 breast cancer, 127 melanoma and 42 healthy control plasma samples.

  Dataset EGAD00001011817

• Circulating tumor DNA, pathological and immunologic responses to neoadjuvant nivolumab or nivolumab plus relatlimab and chemoradiotherapy in resectable esophageal/gastroesophageal junction cancer

  The dataset for the study “Circulating tumor DNA, pathological and immunologic responses to neoadjuvant nivolumab or nivolumab plus relatlimab and chemoradiotherapy in resectable esophageal/gastroesophageal junction cancer” includes 173 bam files from hybrid capture targeted error-correction next-generation sequencing (TEC-Seq) from plasma cell-free DNA and matched white blood cell DNA from 32 individuals with esophageal/gastroesophageal junction cancer, who received immunotherapy-containing regimens.

  Dataset EGAD00001011822

• Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer

  The dataset for the study Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer includes 207 bam files from hybrid capture targeted error-correction next-generation sequencing (TEC-Seq) from plasma cell-free DNA and matched white blood cell DNA from 30 individuals with non-small cell lung cancer, alongside 46 bam files from whole exome sequencing of tumor and matched normal DNA for 21 individuals with non-small cell lung cancer who received immunotherapy-containing regimens.

  Dataset EGAD00001011991

• Shallow-whole genome sequencing for copy numbers in resectable gastric cancer treated with surgery alone

  Shallow-whole genome sequencing for copy numbers in resectable gastric cancer treated with surgery alone

  Dataset EGAD00001011994

• The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients

  Telomere fusions (TFs) can trigger the accumulation of oncogenic alterations leading to malignant transformation and drug resistance. Despite their relevance in tumour evolution, our understanding of the patterns and consequences of TFs in human cancers remains limited. Here, we characterize the rates and spectrum of somatic TFs across >30 cancer types using whole-genome sequencing data. TFs are pervasive in human tumours with rates varying markedly across and within cancer types. In addition to end-to-end fusions, we find novel patterns of TFs that we mechanistically link to the activity of the alternative lengthening of telomeres (ALT) pathway. We show that TFs can be detected in the blood of cancer patients, which enables cancer detection with high specificity and sensitivity even for early-stage tumours and cancers of high unmet clinical need. Overall, we report a novel genomic footprint that enables characterization of the telomere maintenance mechanism of tumours and liquid biopsy analysis.

  Dataset EGAD00001012101

• Geographic variation of mutagenic exposures in kidney cancer genomes – sequence data (Mutographs)

  Geographic variation of mutagenic exposures in kidney cancer genomes – sequence data (Mutographs)

  Dataset EGAD00001012102

• Genome and transcriptome sequence data from a angiosarcoma tumor patient

  Genome and transcriptome sequence data from a angiosarcoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015272

• Genome and transcriptome sequence data from a craniopharyngioma tumor patient

  Genome and transcriptome sequence data from a craniopharyngioma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015273

• Genome and transcriptome sequence data from a NHL large B cell tumor patient

  Genome and transcriptome sequence data from a NHL large B Cell patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015274

• Genome and transcriptome sequence data from a malignant granular cell tumor tumor patient

  Genome and transcriptome sequence data from a malignant granular cell tumor patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015275

• Genome and transcriptome sequence data from a papillary thyroid carcinoma tumor patient

  Genome and transcriptome sequence data from a papillary thyroid carcinoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015276

• Genome and transcriptome sequence data from a neuroblastoma tumor patient

  Genome and transcriptome sequence data from a neuroblastoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015277

• Genome and transcriptome sequence data from a osteosarcoma tumor patient

  Genome and transcriptome sequence data from a osteosarcoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015278

• Genome and transcriptome sequence data from a aggressive fibromatosis tumor patient

  Genome and transcriptome sequence data from a aggressive fibromatosis patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015279

• Genome and transcriptome sequence data from a pineoblastoma tumor patient

  Genome and transcriptome sequence data from a pineoblastoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015280

• Genome and transcriptome sequence data from a multifocal glioblastoma multiforme tumor patient

  Genome and transcriptome sequence data from a multifocal glioblastoma multiforme patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015281

• Genome and transcriptome sequence data from a neuroblastoma tumor patient

  Genome and transcriptome sequence data from a neuroblastoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015302

• Genome and transcriptome sequence data from a progressive facial plexiform neurofibroma tumor patient

  Genome and transcriptome sequence data from a progressive facial plexiform neurofibroma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015282

• Genome and transcriptome sequence data from a plexiform neurofibroma tumor patient

  Genome and transcriptome sequence data from a plexiform neurofibroma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015283

• Genome and transcriptome sequence data from a diffuse intrinsic pontine glioma tumor patient

  Genome and transcriptome sequence data from a diffuse Intrinsic Pontine Glioma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015284

• Genome and transcriptome sequence data from a acute lymphoblastic leukemia tumor patient

  Genome and transcriptome sequence data from a acute lymphoblastic leukemia patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015285

• Genome and transcriptome sequence data from a ewing sarcoma tumor patient

  Genome and transcriptome sequence data from a ewing sarcoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015286

• Genome and transcriptome sequence data from a ependymoma tumor patient

  Genome and transcriptome sequence data from a ependymoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015287

• Genome and transcriptome sequence data from a glioblastoma tumor patient

  Genome and transcriptome sequence data from a glioblastoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015288

• Genome and transcriptome sequence data from a NUT midline carcinoma tumor patient

  Genome and transcriptome sequence data from a NUT midline carcinoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015289

• Genome and transcriptome sequence data from a angiosarcoma tumor patient

  Genome and transcriptome sequence data from a angiosarcoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015290

• Genome and transcriptome sequence data from a pre-B all (2nd relapse in CNS) tumor patient

  Genome and transcriptome sequence data from a pre-B all (2nd relapse in CNS) patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015291

• Genome and transcriptome sequence data from a gliomatosis cerebri anaplastic astrocytoma tumor patient

  Genome and transcriptome sequence data from a gliomatosis cerebri anaplastic astrocytoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015292

• Genome and transcriptome sequence data from a osteosarcoma tumor patient

  Genome and transcriptome sequence data from a osteosarcoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015293

• Genome and transcriptome sequence data from a neuroblastoma tumor patient

  Genome and transcriptome sequence data from a neuroblastoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015294

• Genome and transcriptome sequence data from a metastatic alveolar rhabdomyosarcoma tumor patient

  Genome and transcriptome sequence data from a metastatic alveolar rhabdomyosarcoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015295

• Genome and transcriptome sequence data from a neuroblastoma tumor patient

  Genome and transcriptome sequence data from a neuroblastoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015296

• Genome and transcriptome sequence data from a minimally invasive adenocarcinoma tumor patient

  Genome and transcriptome sequence data from a minimally invasive adenocarcinoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015297

• Genome and transcriptome sequence data from a aggressive fibromatosis tumor patient

  Genome and transcriptome sequence data from a aggressive fibromatosis patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015298

• Genome and transcriptome sequence data from a aggressive fibromatosis tumor patient

  Genome and transcriptome sequence data from a aggressive fibromatosis patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015299

• Genome and transcriptome sequence data from a glioblastoma tumor patient

  Genome and transcriptome sequence data from a glioblastoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015300

• Genome and transcriptome sequence data from a neurofibromatosis type 1 tumor patient

  Genome and transcriptome sequence data from a neurofibromatosis type 1 patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015301

• Genome and transcriptome sequence data from a papillary thyroid carcinoma tumor patient

  Genome and transcriptome sequence data from a papillary thyroid carcinoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015303

• Genome and transcriptome sequence data from a relapsed wilms tumor tumor patient

  Genome and transcriptome sequence data from a relapsed Wilms tumor patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015304

• Genome and transcriptome sequence data from a plexiform neurofibroma tumor patient

  Genome and transcriptome sequence data from a plexiform neurofibroma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015305

• Genome and transcriptome sequence data from a metastatic osteosarcoma tumor patient

  Genome and transcriptome sequence data from a metastatic osteosarcoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015306

• Genome and transcriptome sequence data from a embryonal rhabdomyosarcoma of the nasopharynx tumor patient

  Genome and transcriptome sequence data from a embryonal rhabdomyosarcoma of the nasopharynx patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015307

• Genome and transcriptome sequence data from a diffuse aarge B-cell lymphoma (relapse) tumor patient

  Genome and transcriptome sequence data from a diffuse large B-cell lymphoma (relapse) patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015308

• Genome and transcriptome sequence data from a neuroblastoma tumor patient

  Genome and transcriptome sequence data from a neuroblastoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015309

• Genome and transcriptome sequence data from a malignant rhabdoid tumour tumor patient

  Genome and transcriptome sequence data from a malignant rhabdoid tumour patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015310

• Genome and transcriptome sequence data from a relapsed osteosarcoma tumor patient

  Genome and transcriptome sequence data from a relapsed osteosarcoma patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015311